Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| 1 |
Tesla
TSLA
|
+$1.29B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 3 |
Amazon
AMZN
|
+$812M |
| 4 |
Enbridge
ENB
|
+$695M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$635M |
Top Sells
| 1 |
Apple
AAPL
|
+$352M |
| 2 |
iShares US Medical Devices ETF
IHI
|
+$144M |
| 3 |
Sea Limited
SE
|
+$131M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$130M |
| 5 |
Hilton Grand Vacations
HGV
|
+$109M |
Sector Composition
| 1 | Financials | 23.77% |
| 2 | Technology | 16.96% |
| 3 | Communication Services | 8.91% |
| 4 | Consumer Discretionary | 8.52% |
| 5 | Industrials | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
iShares S&P 100 ETF
OEF
$22.4B
| $44M | 0.02% |
224,320
+220,281
| +5,454% | +$43.2M |
|
527
MongoDB
MDB
$27.2B
| $43.9M | 0.02% |
113,267
+96,363
| +570% | +$37.3M |
|
528
Dynatrace
DT
$14.4B
| $43.8M | 0.02% |
719,600
+606,035
| +534% | +$36.9M |
|
529
NRG Energy
NRG
$31.2B
| $43.8M | 0.02% |
1,096,153
+456,737
| +71% | +$18.2M |
|
530
Dentsply Sirona
XRAY
$2.73B
| $43.7M | 0.02% |
690,996
+88,160
| +15% | +$5.58M |
|
531
ResMed
RMD
$39.6B
| $43.7M | 0.02% |
176,989
+32,502
| +22% | +$8.02M |
|
|
XYZ
532
Block, Inc.
XYZ
$45B
| $43.4M | 0.02% |
173,884
+29,833
| +21% | +$7.44M |
|
533
Methanex
MEOH
$2.98B
| $43.3M | 0.02% |
1,304,856
+56,438
| +5% | +$1.87M |
|
534
J.M. Smucker
SJM
$11.7B
| $43.1M | 0.02% |
329,805
+63,876
| +24% | +$8.36M |
|
|
VRN
535
DELISTED
Veren
VRN
| $42.9M | 0.02% |
9,434,417
-6,454,637
| -41% | -$29.3M |
|
536
Zimmer Biomet
ZBH
$20.3B
| $42.7M | 0.02% |
272,777
+54,174
| +25% | +$8.49M |
|
537
Campbell Soup
CPB
$9.98B
| $42.4M | 0.02% |
924,627
+366,711
| +66% | +$16.8M |
|
538
Cencora
COR
$57.4B
| $42.4M | 0.02% |
369,328
+124,713
| +51% | +$14.3M |
|
539
Royal Caribbean
RCL
$92.8B
| $42.1M | 0.02% |
506,586
+262,591
| +108% | +$21.8M |
|
540
BlackBerry
BB
$2.25B
| $41.8M | 0.02% |
1,847,862
-15,191
| -0.8% | -$343K |
|
541
Generac Holdings
GNRC
$10.9B
| $41.6M | 0.02% |
101,242
+49,408
| +95% | +$20.3M |
|
542
NetEase
NTES
$92.3B
| $41.6M | 0.02% |
362,117
+177,159
| +96% | +$20.3M |
|
543
Bio-Rad Laboratories Class A
BIO
$7.49B
| $41.4M | 0.02% |
64,007
+35,943
| +128% | +$23.3M |
|
544
Quest Diagnostics
DGX
$20.1B
| $41.3M | 0.02% |
310,074
+52,671
| +20% | +$7.02M |
|
545
Qorvo
QRVO
$8.26B
| $41.1M | 0.02% |
206,714
+9,211
| +5% | +$1.83M |
|
546
Moderna
MRNA
$9.46B
| $41.1M | 0.02% |
172,435
+50,557
| +41% | +$12M |
|
547
Burford Capital
BUR
$2.73B
| $41M | 0.02% |
3,724,995
+64,890
| +2% | +$714K |
|
548
East-West Bancorp
EWBC
$14.9B
| $41M | 0.02% |
567,919
+123,385
| +28% | +$8.9M |
|
549
Bank of New York Mellon
BK
$73.3B
| $40.7M | 0.02% |
796,594
+201,785
| +34% | +$10.3M |
|
550
Exelixis
EXEL
$10.1B
| $40.6M | 0.02% |
2,263,311
+511,493
| +29% | +$9.18M |
|